Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18-75 years of age;~* rheumatoid arthritis for \>=3 months and \<=10 years;~* inadequate response to methotrexate (12.5-25mg/week) for \>=3 months;~* evidence of erosive disease and/or clinical synovitis in a signal joint.~Exclusion Criteria:~* autoimmune rheumatic diseases other than RA;~* surgical operations on bones/joints in 12 weeks prior to baseline visit;~* concomitant treatment with biologic agents;~* previous treatment with more than one biologic agent approved for RA, or with cell-depleting therapies.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).